Arax Advisory Partners’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$127K Buy
6,893
+6,176
+861% +$132K ﹤0.01% 2560
2026
Q1
$14.5K Buy
717
+288
+67% +$6.41K ﹤0.01% 2257
2025
Q4
$8.22K Sell
429
-5,783
-93% -$122K ﹤0.01% 2578
2025
Q3
$150K Buy
6,212
+5,712
+1,142% +$133K ﹤0.01% 1373
2025
Q2
$9.73K Buy
500
+448
+862% +$6.62K ﹤0.01% 1978
2025
Q1
$669 Buy
+52
New +$836 ﹤0.01% 2460
2024
Q2
Sell
-2
Closed -$66 2540
2024
Q1
$66 Sell
2
-2
-50% -$68 ﹤0.01% 1297
2023
Q4
$146 Hold
4
﹤0.01% 1293
2023
Q3
$147 Hold
4
﹤0.01% 1289
2023
Q2
$154 Hold
4
﹤0.01% 1243
2023
Q1
$164 Hold
4
﹤0.01% 1241
2022
Q4
$139 Buy
+4
New +$140 ﹤0.01% 1242
2021
Q4
Sell
-4
Closed 1138
2021
Q3
$0 Hold
4
﹤0.01% 987
2021
Q2
$0 Buy
+4
New +$187 ﹤0.01% 915
2018
Q4
Sell
-24
Closed -$1K 557
2018
Q3
$1K Buy
+24
New +$1.08K ﹤0.01% 593

Other funds holding ADNT

Arax Advisory Partners's ADNT Position: Q2 2026 in Review

Arax Advisory Partners increased its Adient (ADNT) stake by 861% in Q2 2026, buying an estimated $132K and bringing the position to 6,893 shares worth $127K. The position accounts for ﹤0.01% of the portfolio, ranked #2560.

Arax Advisory Partners first reported a position in ADNT in Q3 2018 and has held it in 15 quarters since. The position peaked at $150K in Q3 2025. 313 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.

  • Arax Advisory Partners held 6,893 shares of Adient worth $127K as of Q2 2026.
  • Arax Advisory Partners bought 6,176 Adient shares in Q2 2026, an estimated $132K.
  • Adient made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2560 holding.
  • Arax Advisory Partners first reported a position in Adient in Q3 2018 and has held it in 15 quarters since.
  • Arax Advisory Partners's Adient position peaked at $150K in Q3 2025.
  • 313 funds tracked by Wall St. Rank held Adient as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.